ArticleClinical lung cancer2021

Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells.

Dwight H Owen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.